Home » Topics » BioWorld Science

BioWorld Science
RSS

MJFF grant supports Neuropore's development of TLR2 antagonist for Parkinson's disease

April 20, 2022

TAK-676 shows antitumor efficacy as monotherapy or in combination

April 20, 2022

Ono establishes collaborations to discover small molecules targeting GPCRs in metabolic disease

April 20, 2022

Shanghai Visonpharma synthesizes new TLR7 agonists

April 20, 2022

New P2X3 antagonists presented by National Institute of Pharmaceutical R&D

April 20, 2022

Medshine Discovery identifies new CSF-1R inhibitors

April 20, 2022

CSPC Zhongqi Pharmaceutical Technology divulges salts of tyrosine kinase inhibitors

April 20, 2022

Guangzhou Fermion Technology patents new CDK7 inhibitors

April 20, 2022

Plexium compound shows the promise of BRD4 degradation for prostate cancer

April 20, 2022

TLR2/6 agonist AXA-042 shows antitumor activity and tolerability in vivo

April 20, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...